Orion Nutraceuticals Voting Results of the Annual General and Special Meeting of Shareholders held on July 4, 2025

(TheNewswire)

Vancouver, British Columbia – TheNewswire - July 7, 2025 – Orion Nutraceuticals Inc. , (CSE: ORI ) (the “ Company ” or“ Orion ”) announces theresults of the Annual General and Special Meeting held on July 4, 2025(the “ Meeting ”).

The Company is pleased to announce that all matterssubmitted to shareholders for approval as set forth in the Company’sNotice of Meeting and Information Circular, both dated May 20, 2025,were approved at the Meeting.  There were 16 shareholders representedin person or by proxy at the Meeting, holding 4,823,184 common shares,representing 16.46% of the Company’s total issued and outstandingcommon shares as of the record date for the Meeting. The votingresults for each matter presented at the Meeting are set outbelow.

Number of Directors

The resolution to set the number of directors of theCompany at three (3) was approved by the shareholders present orrepresented by proxy at the Meeting who voted on the resolution. Thevoting results are set out below:

Election of Directors

Each of the nominees listed in the Company’sInformation Circular dated May 20, 2025, was elected as a director ofthe Company to hold office for the ensuing year, or until theirsuccessors are elected or appointed. The voting results are set outbelow:

Appointment of Auditors

Dale Matheson Carr-Hilton Labonte LLP was reappointedas auditor of the Company for the ensuing year, with remuneration tobe fixed by the board of directors. The voting results are set outbelow:

Voluntary Delisting from the Canadian Securities Exchange

The Company sought disinterested shareholder approvalto voluntarily delist (the " Delisting ") its common shares from theCanadian Securities Exchange (the " CSE " or the" Exchange "). The voting results are set outbelow:

While disinterested shareholder approval has been obtained for the Delisting,the board of directors continues to review its position. No decisionhas been made at this time, and the board continues to evaluate allavailable options in light of the Company’s strategic and financialpriorities.

Should the board of directors resolve to proceed withthe Delisting from the CSE, a further announcement will be made by wayof news release in accordance with applicable regulatoryrequirements.

Approval of Other Matters

The resolution to transact such other business as mayproperly come before the Meeting, or any adjournment or postponementthereof. The voting results are set out below:

About Orion NutraceuticalsInc.

Orion Nutraceuticals Inc. is actively evaluatingpotential investment and acquisition opportunities. Orion shares tradein Canada on the CSE under the symbol ORI.

ON BEHALF OF THE BOARD

Guy Bourgeois, Director
Tel: ( 604) 687-2038

The CSE hasneither approved nor disapproved the contents of this news release.Neither the CSE nor its Market Regulator (as that term is defined inthe policies of the CSE) accepts responsibility for the adequacy oraccuracy of this news release.

Forward-LookingStatements

This news release contains"forward-looking information" and "forward-lookingstatements" (collectively, “forward-looking statements”)within the meaning of applicable securities laws, including statementsregarding the Company’s intention to delist from CSE, theanticipated benefits of the Delisting, the Company’s ongoingobligations as a reporting issuer, and the potential impact onshareholders and trading liquidity. Forward-looking statements arebased on the opinions, assumptions and estimates of management as ofthe date they are made and are subject to various known and unknownrisks and uncertainties.

These risks include, but are notlimited to, changes in market conditions, regulatory developments, theCompany’s ability to maintain compliance with applicable laws, andother factors that may cause actual outcomes to differ materially fromthose expressed or implied by such forward-looking statements.

Readers are cautioned not to placeundue reliance on forward-looking statements. Except as required byapplicable law, the Company undertakes no obligation to update orrevise any forward-looking statements, whether as a result of newinformation, future events or otherwise.

Copyright (c) 2025 TheNewswire - All rights reserved.